CTS

What CTS does

CTS (CTS Ltd.) is a privately held Israeli pharmaceuticals and consumer healthcare company founded in 1921, headquartered in Hod Hasharon, with manufacturing operations at four sites in Kiryat Malachi, Upper Galilee (CTS Dr. Miron and CTS Novis), and Northern Galilee (CTS Floris). The company operates two business segments. The Healthcare Business develops, produces, markets, and distributes prescription medicines (branded and generics), over-the-counter medicines, food supplements (vitamins, minerals, and supplements), personalized health solutions, consumer goods, and medical devices. The Agriculture Business produces and markets crop protection, crop science, and seed solutions for farmers. Core technology centers on local pharmaceutical formulation via in-house development combined with technology-transfer agreements, executed at manufacturing facilities conforming to strict international and local standards and certifications.

CTS's revenue model combines domestic direct sales in Israel with an export business that has been expanding for three decades through regional and local distributor partnerships. Export geographies include China, Australia, Hong Kong, Taiwan, Singapore, Central America, South Africa, Turkey, Central and Eastern European countries, and Russia. In addition, CTS actively pursues in-licensing partnerships with multinational pharmaceutical companies seeking local marketing rights in Israel and maintains long-standing representation agreements with leading international companies. The marketing footprint is centered on a corporate website (ctspharma.com) and a dedicated business development channel ([email protected]).

CTS is structured around wholly owned operating subsidiaries: CTS Chemical Industries (Kiryat Malachi), CTS Novis (nutritional supplements), CTS Dr. Miron (pharmaceuticals, Upper Galilee), and CTS Floris (cosmetics and manufacturing technologies, Northern Galilee). Founded in 1921, the company reports no recent major M&A, restructuring, or leadership turnover; a fourth funding round involving Fortissimo Capital is recorded as of 2022. Headcount is between 251 and 500 employees, and the company operates as CTS Ltd. under Israeli jurisdiction.

Name

CTS

Legal name

CTS Ltd.

Website

https://eng.cts.co.il

Company type

Private

Founded year

1921

Operating status

Operating

Headcount range

251–500 employees

Short description

CTS is a private Israeli pharmaceuticals and consumer healthcare company founded in 1921, developing, producing, and distributing prescription and OTC medicines, supplements, personalized health, consumer goods, and agricultural solutions through four domestic manufacturing sites and exports to 12+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)

Keywords

• Pharmaceutical manufacturing
• Prescription medicines
• OTC healthcare products
• Food supplements VMS
• Crop protection solutions

Headquarters

HQ city

Hod Hasharon

HQ country

Israel

HQ region

Middle East

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Healthcare Business: Revenue from development, production, marketing, and distribution of prescription branded and generic medicines, OTC medicines, supplements, and medical devices. All products and facilities conform to strict international and local standards and certifications.
2. Agriculture Business: Revenue from production and marketing of agricultural solutions for farmers in crop protection, crop science, and seeds.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

CTS develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products including prescription (branded and generic) and OTC medicines, food supplements and vitamins/minerals, personalized health solutions, consumer goods, and medical devices, alongside agricultural solutions for crop protection, crop science, and seeds. Production is conducted in-house at four advanced Israeli manufacturing sites, supplemented by tech-transfer agreements, with all products and facilities conforming to strict international and local standards.

Product overview

CTS is among Israel's leading pharmaceuticals and consumer healthcare companies, operating since 1921 in two distinct sectors. The Healthcare Business specializes in development, production, marketing, and distribution of prescription (branded and generics) and OTC medicines, supplements, and medical devices. The Agriculture Business focuses on production and marketing of agricultural solutions for farmers in crop protection, crop science, and seeds. The product portfolio comprises five main categories: Prescription pharmaceuticals (branded and generics), Non-Prescription/OTC medicines, Personalized Health solutions, Food Supplements/VMS, and Consumer Goods. Local pharmaceuticals production and formulation activities are based on in-house development and tech-transfer agreements, with all products and facilities conforming to strict international and local standards. The company operates four advanced manufacturing sites nationwide specializing in pharma, nutritional supplements, cosmetics, agriculture, and manufacturing technologies.

Differentiator

Problem solved

Functional benefit

Brands

• Healthcare Business: Specializes in development, production, marketing, and distribution of prescription (branded and generics) and OTC medicines, supplements, and medical devices
• Agriculture Business

Segments2 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Multinational Companies (unspecified)coreStrategic or Co-development PartnerCTS actively seeks new partnerships with multinational companies interested in obtaining marketing rights in Israel for their innovative pharmaceutical products. The company has established long-standing partnerships successfully collaborating and representing leading international companies for the past 3 decades.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Perrigo Company: Global leader in consumer self-care (OTC) and generic prescription pharmaceuticals. Comparable to CTS through its focus on OTC, generics, and consumer health categories, though at vastly greater scale.
• Viatris Inc. Global healthcare company formed from Mylan and Upjohn, focused on generics, branded medicines, and consumer health across 165+ countries. Comparable to CTS in generics/OTC portfolio and international distribution.
• Bayer Consumer Health: Division of Bayer focused on OTC, supplements, and consumer health brands globally. Comparable to CTS in OTC, food supplements/VMS, and consumer goods categories.
• STADA Arzneimittel AG: European-based generics and consumer healthcare company with strong presence in CEE, Russia, and CIS. Comparable to CTS through generics+OTC focus and similar export geographies including CEE and Russia.

Regional players

• Dr. Reddy's Laboratories: Indian-headquartered global pharmaceutical manufacturer with strong generics, OTC, and API businesses across emerging markets including CEE, Russia, and Asia. Comparable to CTS through generics portfolio and similar export geography footprint.

Direct peers

• Dexcel Pharma: Israeli-based pharmaceutical manufacturer focused on generics, OTC, and specialty products with international distribution. Closely comparable to CTS in scale, Israeli origin, generics/OTC mix, and export-oriented model.
• Unipharm: Israeli pharmaceutical company manufacturing and distributing prescription, OTC, and consumer healthcare products. Comparable to CTS in Israeli domicile, multi-category pharma portfolio, and domestic+export distribution model.
• Kamada Ltd. Israeli specialty pharmaceutical company developing, manufacturing, and commercializing plasma-derived therapeutics. Comparable as an Israeli pharma manufacturer with international distribution and formulation-based production.
• Taro Pharmaceutical Industries: Israel-headquartered generic and specialty pharmaceutical manufacturer serving global markets. Comparable to CTS through Israeli domicile, generic+OTC portfolio, and international distribution footprint.
• Teva Pharmaceutical Industries: Israel's largest pharmaceutical company and global generics leader. Directly comparable to CTS as an Israeli-headquartered manufacturer of branded and generic Rx, OTC, and consumer health products with significant export operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ctspharma
• Facebookfacebook.com/cts.pharma
• LinkedInlinkedin.com/company/cts-pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CTS